← Back to Events
GENERAL 7 DAYS AWAY
2026 U.S.-Japan Healthcare
<p>*In-person program Come hear pitches from leading Japanese strategic investors and pharmaceutical companies including AN Ventures, Astellas, Chugai Pharmaceuticals, Daiichi Sankyo, Nippon Life, and Ono Pharmaceuticals. Our presenters will share…</p>\n
75+ Attendees
Coverage & Analysis
🇺🇸 Latest Americas News
All news → May 4 Clene Receives FDA Green Light for CNM-Au8 Accelerated Approval Pathway in ALS Treatment May 4 Alpha Tau's Alpha DaRT Achieves 100% Local Disease Control in Pancreatic Cancer Trials at DDW 2026 May 4 Takeda's TAK-881 Shows Positive Phase 2/3 Results for Primary Immunodeficiency Disease Treatment May 4 Accord Healthcare Relaunches Tadalafil Tablets in Multiple Dosage Strengths, Expanding Generic ED Treatment Access May 4 InspireMD Receives FDA Approval for SwitchGuard Neuro Protection System CGUARDIANS III Pivotal Trial